Scott Gottlieb, M.D., a practicing physician, has served in various capacities at the Food and Drug Administration, including senior adviser for medical technology; director of medical policy development; and, most recently, deputy commissioner for medical and scientific affairs. Dr. Gottlieb has also served as a senior policy adviser at the Centers for Medicare & Medicaid Services. 

Click here to read Scott’s Medical Innovation blog.


  • Member, Policy Board,  Leukemia and Lymphoma Society, 2012-present
  • Member, Public Policy Committee, Society for Hospitalist Medicine, 2011-present
  • Clinical Assistant Professor, New York University School of Medicine, 2011-present
  • Editorial Board, Food and Drug Law Institute’s Policy Forum, 2011-present
  • Board Member, Keystone Center, 2010-present
  • Editorial Board Member, Value-Based Cancer Care, 2009-present
  • Editorial Board Member, Cancer Commons, 2009-present
  • Deputy Commissioner for Medical and Scientific Affairs,  Food and Drug Administration, 2005-2007
  • Author, Forbes-Gottlieb Medical Technology Report; Columnist, 2004-2005
  • Director of Medical Policy Development, Food and Drug Administration, 2004
  • Senior Adviser to the Administrator, Centers for Medicare & Medicaid Services, 2004
  • Senior Adviser for Medical Technology to the Commissioner, Food and Drug Administration, 2003-2004
  • Resident Fellow, AEI, 2002-2003 and 2005
  • Staff Writer, British Medical Journal, 1997-2005
  • Senior Editor, “Pulse,” Journal of the American Medical Association, 1996-2001






M.D., Mount Sinai School of Medicine
B.A., economics, Wesleyan University